Charles F. Wagner Jr., Director of TJX Companies TJX, has filed 0 purchases and 30 sales on the open market. Over the past 12 months that comes to a net sale of $10.8M. The latest trade was on 06/09.

CJ

CJ

Charles F. Wagner Jr.

Director

Company

TJX Companies TJX

First filing

23/02/03

Trades

74 trades

Buys / sales

0 / 30

12-month net buying

−$10.8M

Last trade

06/09

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	01/06	01/08	9,532 sh	$461.00	$4,394,252	−20.2%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	25/12/03	25/12/05	14,000 sh2 trades	$456.00avg.	$6,384,000	−27.1%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	25/03/10	25/03/12	3,298 sh	$500.00	$1,649,000	−6.0%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	24/11/11	24/11/13	3,000 sh	$518.27	$1,554,810	−6.4%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	24/06/03	24/06/05	3,250 sh	$460.00	$1,495,000	−6.5%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	24/05/28	24/05/30	3,250 sh	$454.79	$1,478,067.5	−6.1%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	24/01/02	24/01/04	3,000 sh	$405.00	$1,215,000	−6.4%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	23/11/20	23/11/21	3,000 sh	$349.88	$1,049,640	−6.0%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	23/03/24	23/03/28	1,768 sh	$305.38	$539,911.84	−3.4%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	23/03/17	23/03/21	2,000 sh6 trades	$296.39avg.	$592,786	−3.7%
Vertex PharmaceuticalsVRTX	Open-market sale	23/03/10–23/03/13	23/03/14	4,754 sh14 trades	$291.98avg.	$1,388,054.29	−8.2%